Cochlear Limited (ASX:COH)
93.52
-2.81 (-2.92%)
May 18, 2026, 4:10 PM AEST
Cochlear Revenue
Cochlear had revenue of 1.17B AUD in the half year ending December 31, 2025, with 6.25% growth. This brings the company's revenue in the last twelve months to 2.34B, up 1.28% year-over-year. In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B with 4.81% growth.
Revenue (ttm)
2.34B
Revenue Growth
+1.28%
P/S Ratio
2.62
Revenue / Employee
425.18K
Employees
5,500
Market Cap
6.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.34B | 107.50M | 4.81% |
| Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
| Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
| Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
| Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 139.49M |
| SomnoMed | 118.50M |
| Saluda Medical | 114.04M |
| Aroa Biosurgery | 79.26M |
| Lumos Diagnostics Holdings | 18.31M |
| 4DMedical | 5.81M |
| EBR Systems | 5.80M |
| EMVision Medical Devices | 5.43M |
Cochlear News
- 3 days ago - Regal leads major hedge funds profiting from blue-chip stock woes - The Australian Financial Review
- 5 days ago - The day CBA shares crashed back down to earth - The Australian Financial Review
- 14 days ago - Dig Howitt’s week from hell a sign of the times for health giants - The Australian Financial Review
- 18 days ago - Cochlear caught in market’s deadly crocodile roll - The Australian Financial Review
- 19 days ago - MED-EL USA Presents Real World Clinical Insights to Support Tailored Hearing Solutions at the 2026 American Cochlear Implant Association Meeting - Business Wire
- 26 days ago - Cochlear Shares Plunge 39% After Profit Guidance Cut - GuruFocus
- 26 days ago - Cochlear (COH) Faces Major Stock Drop Amid Weak Market Conditions - GuruFocus
- 26 days ago - Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact - Reuters